Blog Archives

Episode 87: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 2 of 3

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish … Learn more

Episode 86: Clinical Conversations: Therapies and Pharmacotherapy Treatment Options in Pediatrics

In this episode, we will be hearing from Dr. Suzanne Cuda, President and Medical Director for Alamo City Healthy Kids and Families. Joining her is Nancy Browne and Dr. Valarie O’Hara. Nancy is a nurse practitioner, pediatric obesity medicine specialist … Learn more

Episode 85: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 1 of 3

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish … Learn more

Episode 84: Clinical Conversations: NAFLD, The Sentinel Disease of Metabolic Syndrome

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings and Dr. Robert Lustig, discuss non-alcoholic fatty liver disease and obesity. Dr. Lustig is a professor of pediatric in the division of endocrinology at UCSF. In … Learn more

Episode 83: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 3 of 3

In this three part series, Dr. Harold Bays and Dr. Tiffany Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Learn more

Episode 81: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 2 of 3

In this three part series, Dr. Harold Bays and Dr. Tiffany Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Learn more

Episode 78: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk

In this three part series, Dr. Harold Bays and Dr. Tiffany Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Learn more